{"id":23606,"date":"2021-10-05T07:34:18","date_gmt":"2021-10-05T07:34:18","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/it\/?post_type=portfolio-products&p=23606"},"modified":"2022-02-16T14:31:17","modified_gmt":"2022-02-16T14:31:17","slug":"solemantis","status":"publish","type":"portfolio-products","link":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis","title":{"rendered":"Solemantis"},"content":{"rendered":"

Trattamento di pazienti con malattia di Alzheimer da moderata a grave.<\/p>\n","protected":false},"featured_media":23867,"parent":0,"template":"","active-substance":[182],"product-category":[173],"therapeutic-area":[178],"class_list":["post-23606","portfolio-products","type-portfolio-products","status-publish","has-post-thumbnail","hentry","active-substance-memantina","product-category-linea-farmaceutica","therapeutic-area-alzheimer"],"yoast_head":"\nSolemantis - Neuraxpharm Italia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solemantis\" \/>\n<meta property=\"og:description\" content=\"Trattamento di pazienti con malattia di Alzheimer da moderata a grave.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Italia\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-16T14:31:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/08\/25065700\/solemantis.png\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis\",\"url\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis\",\"name\":\"Solemantis - Neuraxpharm Italia\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/08\/25065700\/solemantis.png\",\"datePublished\":\"2021-10-05T07:34:18+00:00\",\"dateModified\":\"2022-02-16T14:31:17+00:00\",\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/08\/25065700\/solemantis.png\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/08\/25065700\/solemantis.png\",\"width\":960,\"height\":960},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/it\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/it\/\",\"name\":\"Neuraxpharm Italia\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Solemantis - Neuraxpharm Italia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis","og_locale":"it_IT","og_type":"article","og_title":"Solemantis","og_description":"Trattamento di pazienti con malattia di Alzheimer da moderata a grave.","og_url":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis","og_site_name":"Neuraxpharm Italia","article_modified_time":"2022-02-16T14:31:17+00:00","og_image":[{"width":960,"height":960,"url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/08\/25065700\/solemantis.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis","url":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis","name":"Solemantis - Neuraxpharm Italia","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis#primaryimage"},"thumbnailUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/08\/25065700\/solemantis.png","datePublished":"2021-10-05T07:34:18+00:00","dateModified":"2022-02-16T14:31:17+00:00","inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.neuraxpharm.com\/it\/portfolio\/solemantis#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/08\/25065700\/solemantis.png","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/5\/2021\/08\/25065700\/solemantis.png","width":960,"height":960},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/it\/#website","url":"https:\/\/www.neuraxpharm.com\/it\/","name":"Neuraxpharm Italia","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/portfolio-products\/23606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/portfolio-products"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/types\/portfolio-products"}],"version-history":[{"count":12,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/portfolio-products\/23606\/revisions"}],"predecessor-version":[{"id":23868,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/portfolio-products\/23606\/revisions\/23868"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/media\/23867"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/media?parent=23606"}],"wp:term":[{"taxonomy":"active-substance","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/active-substance?post=23606"},{"taxonomy":"product-category","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/product-category?post=23606"},{"taxonomy":"therapeutic-area","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/it\/wp-json\/wp\/v2\/therapeutic-area?post=23606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}